However, the trial found that a single dose of Benralizumab ... “This could be a game-changer for people with asthma and COPD. Treatment for asthma and COPD exacerbations has not changed ...
The big advance in the ABRA study is the finding that targeted therapy works in asthma and COPD attacks. "Instead of giving everyone the same treatment, we found targeting the highest risk ...
Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Healio: Healio previously reported on a study that found that respiratory-specific ... There is no curative treatment of COPD, and anything that can reduce the decline in lung function could ...
2010;67(13):1061-1069. Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations. The data of deJong et al. [30] showed no ...